Pro: Active
-
Business
3 analysts upgrade Biogen after success of Alzheimer’s drug, say stocks are making big gains
Three analysts upgraded Biogen after the biotech company reported “best-case” results from the late stages of a study on a…
Read More » -
Business
Investors should not wait for the Fed to rescue the market this time
Even if the market seems to be finding new depths every day, now is probably not a good time to…
Read More » -
Business
These stable value stocks are up this year and pay solid dividends
After a bad week for stocks, CNBC Pro found some stable value names that pay good dividends to help traders…
Read More » -
Business
Inventories are piling up as consumer demand slows. That’s bad news for these stocks
According to Adam Parker of Trivariate Research, it’s time to sell stocks that have high inventories at the same time…
Read More » -
Business
Looking for Profits in Healthcare Stocks During a Market Storm
Investors have viewed healthcare as a mooring in the storm of stock market volatility over the past year. Now, in…
Read More » -
Business
Credit Suisse says buy stocks with this trait popularized by Warren Buffett
Credit Suisse is recommending stocks with characteristics favored by Warren Buffett to investors seeking increased risk in the stock market.…
Read More » -
Business
Wall Street favorite stable stocks include a healthcare name that could rally nearly 60%
Last week, uncertainty dominated Wall Street once again. The S&P 500 index lost 4.8% for its worst weekly performance since…
Read More » -
Business
Wall Street favorite value stocks include a media giant that could rise 55%
The drop in stocks this year has prompted many on Wall Street to look at a previously underappreciated part of…
Read More » -
Business
Cathie Wood calls for a key Fed policy turnaround in three to six months, says outbreak reduction
Ark Invest’s Cathie Wood doubled down on her deflationary call, predicting a major policy reversal from the Federal Reserve as…
Read More » -
Business
UBS cuts year-end S&P 500 forecast, recommends stocks that could perform well in ‘uncertain path ahead’
UBS cut its year-end S&P 500 forecast on concerns that earnings will fall short of expectations as the Federal Reserve…
Read More »